Risk-Based Monitoring (RBM) Implementation: Challenges and Potential Solutions

Area of Science:

• Clinical research
• Drug development
• Regulatory science

Background:

• Risk-based monitoring (RBM) is reshaping traditional clinical trial practices.
• Regulatory bodies and industry forums increasingly endorse RBM.
• Escalating drug development costs and real-time data availability are key drivers for RBM adoption.

Purpose of the Study:

• To analyze the challenges associated with implementing Risk-based monitoring (RBM) in clinical trials.
• To propose potential solutions for overcoming these implementation challenges.

Main Methods:

• Discussion of industry trends and technological advancements.
• Analysis of the interplay between technology, processes, people, and perspectives in RBM.
• Identification of existing challenges and formulation of strategic recommendations.

Main Results:

• The clinical trial industry is transitioning towards RBM acceptance.
• Successful RBM implementation necessitates a holistic approach.
• Numerous challenges impede effective RBM adoption.

Conclusions:

• Addressing the multifaceted challenges of RBM is crucial for successful clinical trial optimization.
• A strategic integration of technological, procedural, human, and cultural elements is vital.
• Overcoming RBM challenges will enhance efficiency and reduce drug development costs.